Correlation Between ABIVAX Socit and Innovator Equity

Can any of the company-specific risk be diversified away by investing in both ABIVAX Socit and Innovator Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABIVAX Socit and Innovator Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ABIVAX Socit Anonyme and Innovator Equity Premium, you can compare the effects of market volatilities on ABIVAX Socit and Innovator Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABIVAX Socit with a short position of Innovator Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABIVAX Socit and Innovator Equity.

Diversification Opportunities for ABIVAX Socit and Innovator Equity

-0.45

Correlation Coefficient

ABIVAX Socit  Innovator Equity

Very good diversification

The 3 months correlation between ABIVAX and Innovator is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding ABIVAX Socit Anonyme and Innovator Equity Premium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovator Equity Premium and ABIVAX Socit is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABIVAX Socit Anonyme are associated (or correlated) with Innovator Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovator Equity Premium has no effect on the direction of ABIVAX Socit i.e., ABIVAX Socit and Innovator Equity go up and down completely randomly.

Pair Corralation between ABIVAX Socit and Innovator Equity

Assuming the 90 days horizon ABIVAX Socit Anonyme is expected to under-perform the Innovator Equity. In addition to that, ABIVAX Socit is 10.29 times more volatile than Innovator Equity Premium. It trades about -0.02 of its total potential returns per unit of risk. Innovator Equity Premium is currently generating about 0.0 per unit of volatility. If you would invest  2,463  in Innovator Equity Premium on December 30, 2024 and sell it today you would lose (2.00) from holding Innovator Equity Premium or give up 0.08% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.41%
Values	Daily Returns

ABIVAX Socit Anonyme  vs.  Innovator Equity Premium

ABIVAX Socit Anonyme

Risk-Adjusted Performance

Very Weak

Over the last 90 days ABIVAX Socit Anonyme has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, ABIVAX Socit is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Innovator Equity Premium

Risk-Adjusted Performance

Weak

Over the last 90 days Innovator Equity Premium has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Innovator Equity is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with ABIVAX Socit and Innovator Equity

The main advantage of trading using opposite ABIVAX Socit and Innovator Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABIVAX Socit position performs unexpectedly, Innovator Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovator Equity will offset losses from the drop in Innovator Equity's long position.

The idea behind ABIVAX Socit Anonyme and Innovator Equity Premium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.